While AGO1 mutations have not been conclusively identified in MDS or AML, its dysregulated silencing could disturb gene expression networks critical for hematopoietic differentiation and leukemogenesis, further highlighting the complexity of miRNA regulation in malignancies. This evidence concerns the gene AGO1 and myelodysplastic syndrome.